Related Experiment Videos

Transitory T-lymphoblastic leukemoid reaction in a neonate with Down syndrome

M Fernandez de Castro1, S Salas, A Martinez

  • 1LaPaz Hospital, Madrid, Spain.

The American Journal of Pediatric Hematology/Oncology
|January 1, 1990
PubMed

Insights

A transient leukemoid reaction in a neonate with Down syndrome resolved spontaneously. This T lymphoblastic proliferation, identified via multiple methods, highlights the need for cytogenetic studies to differentiate from true leukemia.

Area of Science:

  • Hematology
  • Oncology
  • Pediatrics

Background:

  • Down syndrome (trisomy 21) is associated with an increased risk of hematologic malignancies.
  • Neonatal leukemoid reactions can mimic acute leukemia, posing diagnostic challenges.

Observation:

  • A neonate diagnosed with Down syndrome presented with a transient leukemoid reaction.
  • Morphological, cytochemical, and immunological analyses identified the blastic proliferation as T lymphoblastic, specifically prethymocytes.

Findings:

  • The condition exhibited spontaneous complete remission within 8 weeks.
  • Cytogenetic analysis revealed no abnormalities beyond trisomy 21.
  • Distinguishing this transient reaction from true leukemia is crucial.

Implications:

  • Cytogenetic studies are vital for differentiating transient leukemoid reactions from true leukemias in newborns with Down syndrome.
  • In vitro growth patterns of blood and bone marrow may offer additional diagnostic utility.

Related Concept Videos